Clinical Trial Detail

NCT ID NCT02858869
Title Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
Recruitment Recruiting
Gender both
Phase Phase 0
Variant Requirements No
Sponsors Emory University
Indications

melanoma

lung non-small cell carcinoma

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.